Search

Search Constraints

You searched for: Author/Creator Asakawa, Takashi

Search Results

2. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial. Issue 10089 (1st July 2017)

3. Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer. (January 2020)

4. Identification of the type of exercise therapy that affects functioning in patients with early‐stage amyotrophic lateral sclerosis: A multicenter, collaborative study. Issue 5 (30th July 2014)

5. Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm. (1st May 2022)

6. Pharmacologic study (JP28927) of alectinib in Japanese patients with ALK+ non‐small‐cell lung cancer with or without prior crizotinib therapy. Issue 11 (November 2016)